comparemela.com

Latest Breaking News On - Yaron werber - Page 2 : comparemela.com

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript

Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.

United-states
Kansas
Japan
Japanese
Yaron-werber
Anthony-pagano
Tahi-ahmadi
Asthika-goonewardene
James-gordon
Sachin-jain
Judith-klimovsky
Vikram-purohit

Exelixis (EXEL) Q1 2024 Earnings Call Transcript

Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript

Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.27. Roivant Sciences Ltd.

Yaron-werber
Allison-bratzel
Joyce-zhou
David-risinger
Matt-gline
Brian-cheng
Piper-sandler
Stephanie-lee
Mayukh-sukhatme
Fastest-growing-energy-companies
Pfizer

TD Cowen Downgrades 2Seventy Bio Inc. (TSVT) to Market Perform, 'Takeout Uncertain'

TD Cowen Downgrades 2Seventy Bio Inc. (TSVT) to Market Perform, 'Takeout Uncertain'
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Yaron-werber
2seventy-bio-inc
Nasdaq
Market-perform

IPO success stories suggest biotech has reached 'recovery phase'

IPO success stories suggest biotech has reached 'recovery phase'
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Yaron-werber
Td-cowen-werber
Eric-schmidt
Silicon-valley-bank
Portola-pharmaceuticals
Nasdaq
Cantor-fitzgerald
Healthcare-conference
Fierce-biotech
Silicon-valley
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.